1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1

Neurology

Volumn 64, Issue 4, 2005, Pages 608-613

  Dichgans, M ^a,c   Herzog, J ^a   Freilinger, T ^a   Wilke, M ^b   Auer, D P ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; CACNA1A PROTEIN, HUMAN; CALCIUM CHANNEL; CREATINE; DRUG DERIVATIVE; LACTIC ACID DERIVATIVE; N-ACETYLASPARTATE;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; BRAIN CORTEX; BRAIN LEVEL; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CEREBELLUM ATROPHY; CEREBELLUM VERMIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE COURSE; FAMILIAL HEMIPLEGIC MIGRAINE; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; IMAGE ANALYSIS; MALE; MIGRAINE AURA; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; DYSARTHRIA; ESSENTIAL TREMOR; GENETICS; HEMIPLEGIA; METABOLISM; MIDDLE AGED; MIGRAINE WITH AURA; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; VISUAL CORTEX;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN CHEMISTRY; CALCIUM CHANNELS; CEREBELLUM; CHOLINE; CREATINE; DYSARTHRIA; ESSENTIAL TREMOR; FEMALE; GAIT ATAXIA; GLUTAMIC ACID; HEMIPLEGIA; HUMANS; INOSITOL; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MUTATION; PARIETAL LOBE; VISUAL CORTEX;

EID: 13844320584     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000151855.98318.50     Document Type: Article

References (34)

1. Clarke JM. On recurrent motor paralysis in migraine: with report of a family in which recurrent hemiplegia accompanied the attacks. Br Med J 1910;1:1534-1538.
2. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002;125:1379-1391.
3. Olesen J, Bousser MG, Diener HC, et al. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 2004;24(suppl 1).
4. Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001;345:17-24.
5. Elliott MA, Peroutka SJ, Welch S, May EF. Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol 1996;39:100-106.
6. Terwindt GM, Ophoff RA, Haan J, et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. Neurology 1998;50:1105-1110.
7. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5:40-45.
8. 2+ channel gene CACNL1A4. Cell 1996;87:543-552.
9. Ducros A, Denier C, Joutel A, et al. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet 1999;64:89-98.
10. Westenbroek RE, Sakurai T, Elliott EM, et al. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J Neurosci 1995;15:6403-6418.
11. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003;4:386-398.
12. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A CACNA1A knock-in migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004;41:701-710.
13. Ayata C, Shimizu-Sasamata M, Lo EH, Noebels JL, Moskowitz MA. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience 2000;95:639-645.
14. Uncini A, Lodi R, Di Muzio A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 1995;129:214-222.
15. Klockgether T, Schroth G, Diener HC, Dichgans J. Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry 1990;53:297-305.
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Res Med 1993;30:672-679.
17. Ashburner J, Friston K. Multimodal image coregistration and partitioning-a unified framework. Neuroimage 1997;6:209-217.
18. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-313.
19. 1H-MRS. Neurology 2001;56:635-642.
20. Tsai G, Coyle JT. N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995;46:531-540.
21. Kors EE, Terwindt GM, Vermeulen FL, et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 2001;49:753-760.
22. Sasaki H, Kojima H, Yabe I, et al. Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6). Acta Neuropathol (Berl) 1998;95:199-204.
23. Sappey-Marinier D, Vighetto A, Peyron R, Broussolle E, Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol 1999;46:256-259.
24. Koopmans RA, Li DK, Zhu G, Allen PS, Penn A, Paty DW. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet 1993;341:631-632.
25. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437.
26. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
27. Westergaard N, Sonnewald U, Schousboe A. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev Neurosci 1995;17:203-211.
28. Pfund Z, Chugani DC, Juhasz C, et al. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. J Cereb Blood Flow Metab 2000;20:871-878.
29. Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999;53:71-79.
30. Taylor-Robinson SD, Weeks RA, Bryant DJ, et al. Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord 1996;11:167-173.
31. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829-836.
32. Turner TJ, Adams ME, Dunlap K. Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science 1992;258:310-313.
33. Hans M, Luvisetto S, Williams ME, et al. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci 1999;19:1610-1619.
34. Tottene A, Fellin T, Pagnutti S, et al. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 2002;99:13284-13289.